$OGEN·5

ORAGENICS INC · Feb 11, 4:08 PM ET

ORAGENICS INC 5

5 · ORAGENICS INC · Filed Feb 11, 2016

Insider Transaction Report

Form 5
Period: 2015-12-31
Transactions
  • Gift

    Common Stock

    2015-02-021,362,5278,257,742 total(indirect: By KFLP)
  • Other

    Common Stock

    2015-12-131,208,0007,049,742 total
  • Other

    Common Stock

    2015-12-13+400,0001,552,523 total
  • Other

    Common Stock

    2015-12-13+200,000967,878 total
  • Other

    Common Stock

    2015-12-13+400,000919,666 total
  • Other

    Common Stock

    2015-12-13+8,00028,000 total(indirect: By Koski Manage-ment, Inc.)
Holdings
  • Common Stock

    (indirect: By Trust)
    530,851
Footnotes (8)
  • [F1]Robert C. Koski gifted half of his Koski Family Limited Partnership ("KFLP") limited partnership interests constituting 16.5% of KFLP ownership interests in the shares, to five separate irrevocable trusts for the benefit of his children, for which Mr. Koski does not serve as trustee (the "RCK Irrevocable Trusts"). Mr. Koski disclaims beneficial ownership of the shares.
  • [F2]Shares owned directly by KFLP. On December 13, 2015, the Koski Family Limited Partnership ("KFLP") distributed 1,208,000 shares of Oragenics, Inc. common stock to the KFLP's underlying general and limited partners on a pro rata basis in accordance with their ownership interests in the KFLP as follows: Beverly Koski (through Koski Management, Inc.) (8,000); Christine L. Koski 400,000); Thomas L. Koski (400,000); Robert C. Koski; (200,000); and the RCK Irrevocable Trusts (200,000) of which neither the KFLP nor any of its general partners serve as trustees.
  • [F3]The shares are indirectly beneficially owned by each of the KFLP's general partners: Koski Management, Inc. (solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski. Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
  • [F4]Shares owned directly by Christine L. Koski, a director of the Company.
  • [F5]Shares owned directly by Robert C. Koski, a director of the Company.
  • [F6]Shares owned directly by Thomas L. Koski.
  • [F7]Shares owned indirectly by Beverly Koski (through Koski Management, Inc.).
  • [F8]Shares owned by trusts for Mr. Robert Koski's children of which Mr. Robert C. Koski serves as trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (107,600 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (107,600 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (107,600 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (108,051 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.

Documents

1 file
  • 5
    doc5.xmlPrimary

    FORM 5 SUBMISSION